Physician profile
Ryan Wilkin
NPI 1528392628
$982.87
in general payments reported to CMS, 2019-2025
15 companies · $16.05 in 2025
The $16.05 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.94 · 2022: $129 · 2023: $491 · 2024: $303 · 2025: $16.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.74 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $281.66 | 2022-2024 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.23 | 2022-2024 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Genzyme Corporation | $83.65 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $56.67 | 2022-2024 | Fasenra |
| Harmony Biosciences LLC | $53.95 | 2023-2024 | Wakix |
| Glaxosmithkline, LLC. | $48.60 | 2021-2024 | Trelegy Ellipta, Nucala |
| Actelion Pharmaceuticals US, INC. | $40.93 | 2022-2024 | Uptravi, Opsumit |
| Apria Healthcare LLC | $32.17 | 2021 | |
| Mylan Specialty L.P. | $31.60 | 2022-2023 | Yupelri |
| Axsome Therapeutics, INC. | $26.60 | 2023 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $25.12 | 2024 | Dupixent |
| Jazz Pharmaceuticals INC. | $20.09 | 2023 | |
| Abbvie INC. | $19.60 | 2023 | |
| Amgen INC. | $16.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wilkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.